Global Whole Transcriptomics Sequencing Market Research Report 2023

Publication ID:

PB502234753

Publication Date:

February 22, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
Highlights
The global Whole Transcriptomics Sequencing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Whole Transcriptomics Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Whole Transcriptomics Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Whole Transcriptomics Sequencing in Pharmaceutical and Biotechnology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Whole Transcriptomics Sequencing include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Whole Transcriptomics Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Transcriptomics Sequencing.
The Whole Transcriptomics Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Whole Transcriptomics Sequencing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Transcriptomics Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Transcriptomics Sequencing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Transcriptomics Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Whole Transcriptomics Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Transcriptomics Sequencing Market Perspective (2018-2029)
2.2 Whole Transcriptomics Sequencing Growth Trends by Region
2.2.1 Global Whole Transcriptomics Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Whole Transcriptomics Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Whole Transcriptomics Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Whole Transcriptomics Sequencing Market Dynamics
2.3.1 Whole Transcriptomics Sequencing Industry Trends
2.3.2 Whole Transcriptomics Sequencing Market Drivers
2.3.3 Whole Transcriptomics Sequencing Market Challenges
2.3.4 Whole Transcriptomics Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Transcriptomics Sequencing Players by Revenue
3.1.1 Global Top Whole Transcriptomics Sequencing Players by Revenue (2018-2023)
3.1.2 Global Whole Transcriptomics Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Whole Transcriptomics Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Whole Transcriptomics Sequencing Revenue
3.4 Global Whole Transcriptomics Sequencing Market Concentration Ratio
3.4.1 Global Whole Transcriptomics Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Transcriptomics Sequencing Revenue in 2022
3.5 Whole Transcriptomics Sequencing Key Players Head office and Area Served
3.6 Key Players Whole Transcriptomics Sequencing Product Solution and Service
3.7 Date of Enter into Whole Transcriptomics Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Transcriptomics Sequencing Breakdown Data by Type
4.1 Global Whole Transcriptomics Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Whole Transcriptomics Sequencing Forecasted Market Size by Type (2024-2029)
5 Whole Transcriptomics Sequencing Breakdown Data by Application
5.1 Global Whole Transcriptomics Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Whole Transcriptomics Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Whole Transcriptomics Sequencing Market Size (2018-2029)
6.2 North America Whole Transcriptomics Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Whole Transcriptomics Sequencing Market Size by Country (2018-2023)
6.4 North America Whole Transcriptomics Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Transcriptomics Sequencing Market Size (2018-2029)
7.2 Europe Whole Transcriptomics Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Whole Transcriptomics Sequencing Market Size by Country (2018-2023)
7.4 Europe Whole Transcriptomics Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Transcriptomics Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Whole Transcriptomics Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Whole Transcriptomics Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Whole Transcriptomics Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Transcriptomics Sequencing Market Size (2018-2029)
9.2 Latin America Whole Transcriptomics Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Whole Transcriptomics Sequencing Market Size by Country (2018-2023)
9.4 Latin America Whole Transcriptomics Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Transcriptomics Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Whole Transcriptomics Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Whole Transcriptomics Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Whole Transcriptomics Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Whole Transcriptomics Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Whole Transcriptomics Sequencing Introduction
11.2.4 Illumina Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Whole Transcriptomics Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Whole Transcriptomics Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Whole Transcriptomics Sequencing Introduction
11.5.4 Roche Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Whole Transcriptomics Sequencing Introduction
11.6.4 GE Healthcare Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Whole Transcriptomics Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Whole Transcriptomics Sequencing Introduction
11.8.4 Fluidigm Revenue in Whole Transcriptomics Sequencing Business (2018-2023)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂